Subfoveal Choroidal Thickness after Ranibizumab Therapy for Neovascular Age-related Macular Degeneration: 12-Month Results
Ophthalmology, 05/04/2012
Clinical Article
Yamazaki T et al. – Subfoveal choroidal thickness decreased after intravitreal injections of ranibizumab in eyes with neovascular age–related macular degeneration. Intravitreal injections of ranibizumab may provide a pharmacologic effect not only on the neovascular lesion but also on the underlying choroid.



